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Background
The state between normal cognition and dementia is
known as mild cognitive impairment (MCI) [1]. While
cognitive impairment that does not meet the clinical crite-
ria for dementia is common, it is known that MCI, is asso-
ciated with an increased risk of developing dementia
[2,3]. Worse performance on neuropsychological tests (>1
SD from the mean performance) is a significant marker of
cognitive impairment [4]. The purpose of the present
study is to assess neuropsychological functions in clini-
cally diagnosed MCI subjects and to determine evidence
of preclinical dementia.
Materials and methods
One hundred and three (N = 103) patients who met the
clinical criteria for MCI were assessed and after 12
months, thirty five patients of them (N = 35) were re-
assessed, since during the first examination, their per-
formance on memory tests and other cognitive tests devi-
ated significantly from performance of healthy controls
(N = 121). All patients underwent an extensive series of
neuropsychological tests, covered many cognitive
domains [4].
Results
MCI subjects showed poorer performance compared to
controls, especially on tests of verbal and visual memory
(p.000). However, they constituted a heterogeneous
group, since re-examination revealed subgroups a) with
improved performance and/or no more decline because
of reversible reasons, b) with stable performance without
further decline and c) with progressive decrease of per-
formance and decline in many cognitive domains. Sub-
jects with decline in multiple cognitive domains, apart
from memory, constituted a homogeneous group with
distinctive neuropsychological characteristics. Between
test re-test, the range of scores on neuropsychological tests
was found to increase. Moreover, this group performed
significantly worse (p.000) on tests that assess speed of
information processing, recall of meaningful new seman-
tic and visual material, amount and rate of verbal learn-
ing, abstract reasoning and executive functions. The
above-mentioned dysfunctions progressively resulted in
decline of intelligence (verbal cognitive functions and vis-
uomotor dexterities).
Conclusions
Given their performance on an extensive neuropsycholog-
ical battery, subjects with clinical MCI show a characteris-
tic profile of dysfunctions with decline in multiple
cognitive domains. Test re-test assessments provide
increased evidence that these multiple cognitive impaired
subjects constitute a homogeneous group with high risk
of conversion to dementia.
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